Charles River Laboratories International, headquartered in Wilmington, Massachusetts, provides products and services to pharmaceutical and biotechnology companies with 20,000 employees. The company offers research models, safety assessment, and manufacturing solutions since its IPO in 2000.
Joseph W Laplume sold 4,400 shares of CRL on 20 February at $162.50 per share, worth a total of $715K. They now own 20,013 CRL shares, or a 18% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.